Empty Capsules Market Size, Trends and Insights By Type (Gelatin Capsules, Non-gelatin Capsules), By Functionality (Immediate-release Capsules, Sustained-release Capsules, Delayed-release Capsules), By Application (Antibiotic & Antibacterial Drugs, Vitamin & Dietary Supplements, Antacid & Antiflatulent Preparations, Cardiovascular Therapy Drugs, Other), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034
Report Snapshot
Study Period: | 2024-2033 |
Fastest Growing Market: | Asia-Pacific |
Largest Market: | Europe |
Major Players
- ACG
- Sunil Healthcare Limited
- H & CARE Incorp
- SavoiurCaps
- Comed Chemicals Limited
- Others
Reports Description
Global Empty Capsule Market was valued at USD 2.98 Billion in 2025 and is expected to reach USD 4.61 Billion by 2034, at a CAGR of 5.26% during the forecast period 2025- 2034.
The manufacturing of empty capsules, usually made from gelatine or other plant materials, currently comprises a global market. The empty capsules are meant to encapsulate drugs supplements or other substances to form an efficient system of drug delivery with advantages such as better bioavailability, easy swallowing, accurate dosages, and masking of an unpleasant taste or smell.
They are utilized broadly in pharmaceuticals, nutraceuticals, and dietary supplements, making them essential components in projects aimed at meeting the needs of various demographics such as the elderly population, vegans, and those with special medical conditions.
Empty Capsules Market: Growth Factors
Rising Incidence of Chronic Diseases
The growing incidences of various chronic diseases such as diabetes, cardiovascular disorders, and cancer are increasingly responsible for driving empty capsule demand. Most of these conditions need long-term medications for which capsules are preferred as a form of drug delivery because they are easier to swallow and have an accurate dose.
For instance, in India statistics show that chronic diseases are the leading cause of death in India, accounting for 60% of all deaths annually, killing more than 5 million people every year. Empty capsules can mask unpleasant tastes-preference entirely promotes adherence by patients.
Moreover, the advancement in drug formulation, along with the development of sustained-release and targeted-release capsules, has influenced the effectiveness of capsules in managing chronic conditions. The increasing world population aging, which is most affected by chronic diseases, has stimulated further demand for capsule treatments.
Pharmaceutical companies are now gravitating towards capsules because of their flexibility to encapsulate any type of drug whether in liquid, powder, or granule form, making it an upcoming growth driver of the market over the coming years.
Growing Demand for Nutraceuticals Drives Market Expansion
Capsules have significantly met the consumer demand in nutraceuticals due to heightening consciousness on health. Nutraceutical capsules are widely consumed in these applications for vitamins, minerals, herbal extracts, or other supplements. Such dietary supplements have been widely consumed in North America and Asia Pacific, primarily due to their preventive healthcare nature becoming alive for most sections of the population.
Furthermore, the rapidly expanding global nutraceutical industry is expected to boost the consumption of empty capsules during the forecast period. The increasing popularity of vegetarianism and veganism among people is another driver of the niche market as they look for plant-derived capsule offerings, such as those from hydroxypropyl methylcellulose (HPMC).
Along with this phenomenon, capsule manufacturers are showing innovation in their presentation by offering alternatives to gelatine and clean labels. The effect of personalization on nutrition has compelled the industry to forge specialized nutraceutical capsules that address specific health needs. This expanding consumer base is just a boost for the empty capsules market.
Growing Plant-Based Capsule Adoption
Rising demand for plant-based or vegan empty capsules is boosting the overall market for empty capsules market. These vegetarian capsules, made principally from HPMC, can gain more acceptance by health-conscious and diet-restricted consumers. With awareness growing about the environmental impacts of animal-derived products, manufacturers are seriously leaning towards sustainable and plant-based capsule production.
Emerging markets in the Asia Pacific and Latin America where vegetarianism forms a given cultural practice define unexplored regions for continued growth. Such companies will create a superior competitive advantage for themselves and subsequently increase market growth, by owning R&D investments in developing new greening capsules.
Empty Capsules Market: Restraints
The High Cost of Raw Materials
The increase in raw material costs, especially for gelatine and other components in vegetarian empty capsules such as HPMC, is one of the major challenges facing the empty capsules market. Gallatin is an animal-derived raw material, price volatile due to supply chain disruptions and growing environmental and ethical concerns. The vegetarian option is even more expensive for production because of these ethical issues.
The other significant barriers to producing high-end capsules are advanced technology and very stringent regulatory compliance. Thus, they will shoot manufacturing costs. All these lead to high-end consumer pricing, which restricts the market growth potential, especially in cost-sensitive areas.
Regulatory Challenges Impede Market Expansion
The stringent regulatory environment in the pharmaceutical and nutraceutical industries restrains the empty capsule market. Varying regional regulations regarding capsule manufacturing, raw material sourcing, and product approval processes affect the manufacturers. They are required to follow the stringent standards laid by the agencies like the FDA in the U.S. or the EMA in Europe.
This is a very time-consuming process and involves a lot of costs. Also, continuous updates in illegal regulatory guidelines can put manufacturing companies in a fix with delayed product launches and increased complexities. Such challenges discourage new entrants and have an impact on profitability for the existing players over market growth.
Empty Capsules Market: Opportunities
Customized medicine elevates capsule innovations
Personalized medicine is naturally offering huge business prospects for the empty capsules industry. It is the aspect of advances in healthcare technology such as genomics and artificial intelligence diagnostics that offer customized treatment per patient.
Drug combinations or dosages may be well encapsulated using capsules, which has contributed to a growing demand for small-batch production of capsules for individualized medications mainly in oncology and rare disease facilities. It would be advisable for companies to pursue this new niche of providing customizable capsule solutions.
Technological Advancements in Capsule Manufacturing
The future empty capsules market is transformed by technology development. Increased efficiency and higher quality of products in capsule manufacturing come from advances in automation and precision engineering. Microscopic capsule production, liquid formulations encapsulation, and capsules with multi-phase drug release are widely applied.
The transition to digitized manufacturing has made it possible to monitor and control quality in real time and to significantly reduce production error and waste. In addition, manufacturers are exploring smart capsules with embedded sensors that make advanced drug delivery systems possible. Innovation sets a new standard in the industry and is expected to be one of the trends shaping its future.
Growth in capsule production in emerging countries
The pharmaceutical market has come from experiencing a profitably huge boost to now being starved for growth because of diminishing products in the pipeline, the contemplation of costs caused by governments, and regulatory strangulation concerning innovative products.
The drug manufacturers are relocating to hurdling developing regions for manufacturing for many visibilities low-cost manufacturing opportunities and also psychological benefits such as favourable tax ratio and flexible regulations. Mostly, big pharmaceutical companies now either increase the production capacity of their old facilities in emerging markets or build new plants in countries such as China and India; increasingly empty capsules are, thus, in demand.
Empty Capsules Market: Segmentation Analysis
Based on type global empty capsules market is segmented into Gallatin capsules and non-gelatine capsules. Among all of these, the gelatine capsules segment held the largest market share of 78% and is expected to continue dominating the market during the forecast period. Gallatin capsules are preferred mostly as a capsule shell because of many advantages such as rapid release of the drug, uniform mixing of the drug, and barrier against ambient oxygen.
Other factors related to the usage of gelatine in pharmaceutical products include easy availability of raw materials, cost-effectiveness, and easy process of production. To make capsules most affordable, the companies have switched to alternative low-cost raw materials like gelatine because they eventually reduced operating costs in the pharmaceutical industry.
Based on functionality market is segmented by immediate-release capsules, sustained-release capsules, and delayed-release capsules. Among all of these, the immediate-release capsules segment is expected to grow at the fastest CAGR during the forecast period.
An immediate effect is delivered by instant-release capsules when taken in. Therefore, they are extensively used in formulating large numbers of healthcare products such as antacids and pain relief medicines. The reasons would fuel the global growth in demand for immediate-release capsules.
Report Scope
Feature of the Report | Details |
Market Size in 2025 | USD 2.98 Billion |
Projected Market Size in 2034 | USD 4.61 Billion |
Market Size in 2024 | USD 2.76 Billion |
CAGR Growth Rate | 5.26% CAGR |
Base Year | 2024 |
Forecast Period | 2025-2034 |
Key Segment | By Type, Functionality, Application and Region |
Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Empty Capsules Market: Regional Analysis
By region, the Global empty capsules market is segmented into North America, Asia Pacific, Europe, Middle East & Africa and Latin America. Among all of these, North America is expected to account for a 36.5% share of the overall empty capsules market during the forecast period.
Demand for such empty capsules is propelled by the increasing consumption of pharmaceuticals and nutraceuticals, the presence of major market players, increasing consumer preference regarding vegetarian empty capsules, government support, and increasing need for preventive care, among others.
The two conditions that boost the demand for nutraceuticals in the US, due to poor lifestyle choices, create an enormous demand for them to regulate adequate nutrient consumption and further increase sales of empty supplement capsules and empty vitamin capsules. The major countries such as the U.S., Canada and Mexico are mainly driving the market growth of this region.
Asia Pacific region is expected to grow the fastest CAGR during the forecast period owing to the following factors rapid development and proliferation of pharmaceutical industries in developing nations, government initiatives in encouraging public and private-private partnership efforts in developing and expanding healthcare infrastructure and growing awareness and demand for nutraceuticals and cosmeceuticals as the payoffs of wellness trends and changing lifestyles promoting fitness. The key countries such as China, India, Japan, ASEAN and South Korea are mainly driving the market growth of this region.
Europe region is expected to hold a substantial market share during the forecast period owing to the growing stringent regulations on capsulation. The key countries such as Germany, France, the U.K., Russia, Italy and Spain are mainly driving the market growth of this region.
Empty Capsules Market: Recent Developments
- In September last year, Eli Lilly announced a tie-up with Egypt’s Eva Pharma in a tie-up to license manufacturing know-how for Olumiant (baricitinib), the company’s rheumatoid arthritis medication intended to eventually produce the drug in Africa. Under the agreement, Eva Pharma will supply Olumiant to 49 African countries.
- In July 2024, when Novo The top global insulin producer- became a partner with Bio Farma state-owned enterprise in Indonesia that produces insulin locally. Novo Nordisk will provide know-how and experience in diabetes treatment and insulin manufacture while Bio Farma will take advantage of local manufacturing. The investment amounts and commence date of manufacture are still being finalized, which shows a strong commitment by Novo Nordisk to improving diabetes management within Indonesia.
- In October 2024, Eli Lilly will announce an increase in investments by $4.5 billion towards enhancing manufacturing and drug development capability. It has planned to expand its Indianapolis headquarters and set up another site intended to house advanced manufacturing and drug development in 2025. This facility termed the Lilly Medicine Foundry, will be devoted to grounds of innovative drug research and development into clinical trials.
List of the prominent players in the Empty Capsules Market:
- ACG
- Sunil Healthcare Limited
- H & CARE Incorp
- SavoiurCaps
- Comed Chemicals Limited
- Natural Capsules Limited
- HealthCaps India Ltd
- Erawat Pharma Limited
- Fortcaps Healthcare Ltd
- Nectar Lifesciences Limited
- Bio Caps India Ltd
- NecLife Lifesciences Ltd
- Medi-Caps Ltd
- Wuhan Carma Technology Co. Ltd
- Shaoxing Kangke Capsule Co. Ltd
- Snail Pharma Industry
- Aipak Pharma
- Suheung Co. Ltd
- CapsCanada
- Bright Pharma Caps.
- Others
The Empty Capsules Market is segmented as follows:
By Type
- Gelatin Capsules
- Non-gelatin Capsules
By Functionality
- Immediate-release Capsules
- Sustained-release Capsules
- Delayed-release Capsules
By Application
- Antibiotic & Antibacterial Drugs
- Vitamin & Dietary Supplements
- Antacid & Antiflatulent Preparations
- Cardiovascular Therapy Drugs
- Others
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market Research Methodology
- Chapter 2. Executive Summary
- 2.1 Global Empty Capsules Market, (2025 – 2034) (USD Million)
- 2.2 Global Empty Capsules Market: snapshot
- Chapter 3. Global Empty Capsules Market – Industry Analysis
- 3.1 Empty Capsules Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Rising Incidence of Chronic Diseases
- 3.2.2 Growing Demand for Nutraceuticals Drives Market Expansion
- 3.2.3 Growing Plant-Based Capsule Adoption
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Functionality
- 3.7.3 Market Attractiveness Analysis By Application
- Chapter 4. Global Empty Capsules Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Empty Capsules Market: Company Market Share, 2024
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, collaboration, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Empty Capsules Market – Type Analysis
- 5.1 Global Empty Capsules Market Overview: By Type
- 5.1.1 Global Empty Capsules Market Share, By Type, 2024 and 2034
- 5.2 Gelatin Capsules
- 5.2.1 Global Empty Capsules Market by Gelatin Capsules, 2025 – 2034 (USD Million)
- 5.3 Non-gelatin Capsules
- 5.3.1 Global Empty Capsules Market by Non-gelatin Capsules, 2025 – 2034 (USD Million)
- 5.1 Global Empty Capsules Market Overview: By Type
- Chapter 6. Global Empty Capsules Market – Functionality Analysis
- 6.1 Global Empty Capsules Market Overview: By Functionality
- 6.1.1 Global Empty Capsules Market Share, By Functionality, 2024 and 2034
- 6.2 Immediate-release Capsules
- 6.2.1 Global Empty Capsules Market by Immediate-release Capsules, 2025 – 2034 (USD Million)
- 6.3 Sustained-release Capsules
- 6.3.1 Global Empty Capsules Market by Sustained-release Capsules, 2025 – 2034 (USD Million)
- 6.4 Delayed-release Capsules
- 6.4.1 Global Empty Capsules Market by Delayed-release Capsules, 2025 – 2034 (USD Million)
- 6.1 Global Empty Capsules Market Overview: By Functionality
- Chapter 7. Global Empty Capsules Market – Application Analysis
- 7.1 Global Empty Capsules Market Overview: By Application
- 7.1.1 Global Empty Capsules Market Share, By Application, 2024 and 2034
- 7.2 Antibiotic & Antibacterial Drugs
- 7.2.1 Global Empty Capsules Market by Antibiotic & Antibacterial Drugs, 2025 – 2034 (USD Million)
- 7.3 Vitamin & Dietary Supplements
- 7.3.1 Global Empty Capsules Market by Vitamin & Dietary Supplements, 2025 – 2034 (USD Million)
- 7.4 Antacid & Antiflatulent Preparations
- 7.4.1 Global Empty Capsules Market by Antacid & Antiflatulent Preparations, 2025 – 2034 (USD Million)
- 7.5 Cardiovascular Therapy Drugs
- 7.5.1 Global Empty Capsules Market by Cardiovascular Therapy Drugs, 2025 – 2034 (USD Million)
- 7.6 Other
- 7.6.1 Global Empty Capsules Market by Other, 2025 – 2034 (USD Million)
- 7.1 Global Empty Capsules Market Overview: By Application
- Chapter 8. Empty Capsules Market – Regional Analysis
- 8.1 Global Empty Capsules Market Regional Overview
- 8.2 Global Empty Capsules Market Share, by Region, 2024 & 2034 (USD Million)
- 8.3. North America
- 8.3.1 North America Empty Capsules Market, 2025 – 2034 (USD Million)
- 8.3.1.1 North America Empty Capsules Market, by Country, 2025 – 2034 (USD Million)
- 8.3.1 North America Empty Capsules Market, 2025 – 2034 (USD Million)
- 8.4 North America Empty Capsules Market, by Type, 2025 – 2034
- 8.4.1 North America Empty Capsules Market, by Type, 2025 – 2034 (USD Million)
- 8.5 North America Empty Capsules Market, by Functionality, 2025 – 2034
- 8.5.1 North America Empty Capsules Market, by Functionality, 2025 – 2034 (USD Million)
- 8.6 North America Empty Capsules Market, by Application, 2025 – 2034
- 8.6.1 North America Empty Capsules Market, by Application, 2025 – 2034 (USD Million)
- 8.7. Europe
- 8.7.1 Europe Empty Capsules Market, 2025 – 2034 (USD Million)
- 8.7.1.1 Europe Empty Capsules Market, by Country, 2025 – 2034 (USD Million)
- 8.7.1 Europe Empty Capsules Market, 2025 – 2034 (USD Million)
- 8.8 Europe Empty Capsules Market, by Type, 2025 – 2034
- 8.8.1 Europe Empty Capsules Market, by Type, 2025 – 2034 (USD Million)
- 8.9 Europe Empty Capsules Market, by Functionality, 2025 – 2034
- 8.9.1 Europe Empty Capsules Market, by Functionality, 2025 – 2034 (USD Million)
- 8.10 Europe Empty Capsules Market, by Application, 2025 – 2034
- 8.10.1 Europe Empty Capsules Market, by Application, 2025 – 2034 (USD Million)
- 8.11. Asia Pacific
- 8.11.1 Asia Pacific Empty Capsules Market, 2025 – 2034 (USD Million)
- 8.11.1.1 Asia Pacific Empty Capsules Market, by Country, 2025 – 2034 (USD Million)
- 8.11.1 Asia Pacific Empty Capsules Market, 2025 – 2034 (USD Million)
- 8.12 Asia Pacific Empty Capsules Market, by Type, 2025 – 2034
- 8.12.1 Asia Pacific Empty Capsules Market, by Type, 2025 – 2034 (USD Million)
- 8.13 Asia Pacific Empty Capsules Market, by Functionality, 2025 – 2034
- 8.13.1 Asia Pacific Empty Capsules Market, by Functionality, 2025 – 2034 (USD Million)
- 8.14 Asia Pacific Empty Capsules Market, by Application, 2025 – 2034
- 8.14.1 Asia Pacific Empty Capsules Market, by Application, 2025 – 2034 (USD Million)
- 8.15. Latin America
- 8.15.1 Latin America Empty Capsules Market, 2025 – 2034 (USD Million)
- 8.15.1.1 Latin America Empty Capsules Market, by Country, 2025 – 2034 (USD Million)
- 8.15.1 Latin America Empty Capsules Market, 2025 – 2034 (USD Million)
- 8.16 Latin America Empty Capsules Market, by Type, 2025 – 2034
- 8.16.1 Latin America Empty Capsules Market, by Type, 2025 – 2034 (USD Million)
- 8.17 Latin America Empty Capsules Market, by Functionality, 2025 – 2034
- 8.17.1 Latin America Empty Capsules Market, by Functionality, 2025 – 2034 (USD Million)
- 8.18 Latin America Empty Capsules Market, by Application, 2025 – 2034
- 8.18.1 Latin America Empty Capsules Market, by Application, 2025 – 2034 (USD Million)
- 8.19. The Middle-East and Africa
- 8.19.1 The Middle-East and Africa Empty Capsules Market, 2025 – 2034 (USD Million)
- 8.19.1.1 The Middle-East and Africa Empty Capsules Market, by Country, 2025 – 2034 (USD Million)
- 8.19.1 The Middle-East and Africa Empty Capsules Market, 2025 – 2034 (USD Million)
- 8.20 The Middle-East and Africa Empty Capsules Market, by Type, 2025 – 2034
- 8.20.1 The Middle-East and Africa Empty Capsules Market, by Type, 2025 – 2034 (USD Million)
- 8.21 The Middle-East and Africa Empty Capsules Market, by Functionality, 2025 – 2034
- 8.21.1 The Middle-East and Africa Empty Capsules Market, by Functionality, 2025 – 2034 (USD Million)
- 8.22 The Middle-East and Africa Empty Capsules Market, by Application, 2025 – 2034
- 8.22.1 The Middle-East and Africa Empty Capsules Market, by Application, 2025 – 2034 (USD Million)
- Chapter 9. Company Profiles
- 9.1 ACG
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Sunil Healthcare Limited
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 H & CARE Incorp
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 SavoiurCaps
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Comed Chemicals Limited
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Natural Capsules Limited
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 HealthCaps India Ltd
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Erawat Pharma Limited
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Fortcaps Healthcare Ltd
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Nectar Lifesciences Limited
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Bio Caps India Ltd
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 NecLife Lifesciences Ltd
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 Medi-Caps Ltd
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 Wuhan Carma Technology Co. Ltd
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Shaoxing Kangke Capsule Co. Ltd
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 Snail Pharma Industry
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 Aipak Pharma
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.18 Suheung Co. Ltd
- 9.18.1 Overview
- 9.18.2 Financials
- 9.18.3 Product Portfolio
- 9.18.4 Business Strategy
- 9.18.5 Recent Developments
- 9.19 CapsCanada
- 9.19.1 Overview
- 9.19.2 Financials
- 9.19.3 Product Portfolio
- 9.19.4 Business Strategy
- 9.19.5 Recent Developments
- 9.20 Bright Pharma Caps.
- 9.20.1 Overview
- 9.20.2 Financials
- 9.20.3 Product Portfolio
- 9.20.4 Business Strategy
- 9.20.5 Recent Developments
- 9.21 Others.
- 9.21.1 Overview
- 9.21.2 Financials
- 9.21.3 Product Portfolio
- 9.21.4 Business Strategy
- 9.21.5 Recent Developments
- 9.1 ACG
List Of Figures
Figures No 1 to 26
List Of Tables
Tables No 1 to 77
Prominent Player
- ACG
- Sunil Healthcare Limited
- H & CARE Incorp
- SavoiurCaps
- Comed Chemicals Limited
- Natural Capsules Limited
- HealthCaps India Ltd
- Erawat Pharma Limited
- Fortcaps Healthcare Ltd
- Nectar Lifesciences Limited
- Bio Caps India Ltd
- NecLife Lifesciences Ltd
- Medi-Caps Ltd
- Wuhan Carma Technology Co. Ltd
- Shaoxing Kangke Capsule Co. Ltd
- Snail Pharma Industry
- Aipak Pharma
- Suheung Co. Ltd
- CapsCanada
- Bright Pharma Caps.
- Others
FAQs
The key factors driving the Market are Increasing health consciousness, coupled with a growing preference for preventive healthcare.
The “Antibiotic & Antibacterial Drugs” had the largest share in the global market for Empty Capsules.
The “Gelatin Capsules” category dominated the market in 2024.
The key players in the market are ACG, Sunil Healthcare Limited, H & CARE Incorp, SavoiurCaps, Comed Chemicals Limited, Natural Capsules Limited, HealthCaps India Ltd, Erawat Pharma Limited, Fortcaps Healthcare Ltd, Nectar Lifesciences Limited, Bio Caps India Ltd, NecLife Lifesciences Ltd, Medi-Caps Ltd, Wuhan Carma Technology Co. Ltd, Shaoxing Kangke Capsule Co. Ltd, Snail Pharma Industry, Aipak Pharma, Suheung Co. Ltd, CapsCanada, Bright Pharma Caps., Others.
“North America” had the largest share in the Empty Capsules Market.
The global market is projected to grow at a CAGR of 5.26% during the forecast period, 2025-2034.
The Empty Capsules Market size was valued at USD 2.98 Billion in 2025.